| Autor: |
Walker, John M., Langdon, Simon P., Scott, William N. |
| Zdroj: |
Cancer Cell Culture; 2004, p239-246, 8p |
| Abstrakt: |
Considerable data on the mechanisms of angiogenesis and neovascularization form the basis for clinical interventions aimed at both inhibiting and promoting vessel growth. Antiangiogenic therapy is desirable in proliferative diabetic retinopathy and in some forms of macular degeneration, as well as being an alternative mode of antitumor therapy (1). In contrast, proangiogenesis is directed towards the formation of new vessels or collaterals. This outcome is desirable in disorders characterized by tissue ischemia, such as myocardial infarction or peripheral vascular disease (2). [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
